ketamine has been researched along with Brachial Paresis in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ilahi, Z | 1 |
Janardhan, S | 1 |
Dave, M | 1 |
Khariton, M | 1 |
Feuer, P | 1 |
Venkataraman, A | 1 |
Romanos-Sirakis, E | 1 |
Agarwal, R | 1 |
Roitman, KJ | 1 |
Stokes, M | 1 |
2 other studies available for ketamine and Brachial Paresis
Article | Year |
---|---|
Ketamine as an Adjunct for Treatment of Methotrexate-induced Neurotoxicity.
Topics: Child; Homocysteine; Humans; Ketamine; Methotrexate; Neurotoxicity Syndromes; Paresis | 2022 |
Improvement of intraoperative somatosensory evoked potentials by ketamine.
Topics: Anesthetics, Dissociative; Anesthetics, Intravenous; Astrocytoma; Child; Evoked Potentials, Somatose | 1998 |